XELLIA PHARMACEUTICALS ApS
XELLIA PHARMACEUTICALS ApS is a Private limited company (Ltd.) registered in Denmark under 61094628, and its current status with Danish Business Authority — CVR (Central Business Register) is active. The company was incorporated on 31 March 1959 and lists its registered address as København S, Denmark. 1 shareholder is on record for XELLIA PHARMACEUTICALS ApS, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for XELLIA PHARMACEUTICALS ApS, filed with Danish Business Authority — CVR (Central Business Register).
The largest of these is XELLIA GROUP ApS, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| XELLIA GROUP ApS | 100% | Danish Business Authority — CVR (Central Business Register) |
Officers
5
Three of the 5 officer records shown for XELLIA PHARMACEUTICALS ApS are current appointments, filed with Danish Business Authority — CVR (Central Business Register). Stig Strobæk, Lars Fugger and Ole Jakob Muller all serve as Reel Ejer. The remaining 2 records shown (Frank Jensen and Jan Hogh Bergmann) are former appointments that have since been resigned.
The register reports 83 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at XELLIA PHARMACEUTICALS ApS sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
XELLIA PHARMACEUTICALS ApS sits 7 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark. 6 subsidiaries are recorded beneath it, across 7 jurisdictions. Immediately above XELLIA PHARMACEUTICALS ApS is Xellia Group ApS, holding 100% as filed in XELLIA PHARMACEUTICALS ApS's own shareholder record with Danish Business Authority — CVR (Central Business Register). Novo Nordisk Fonden sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 6 subsidiaries span Denmark, Hong Kong, China, Hungary, Croatia, United States, and 1 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 6 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Novo Nordisk Fonden
Denmark
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns XELLIA PHARMACEUTICALS ApS?
One shareholder is currently on record for XELLIA PHARMACEUTICALS ApS, filed with Danish Business Authority — CVR (Central Business Register). The largest of these is XELLIA GROUP ApS, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is XELLIA PHARMACEUTICALS ApS's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for XELLIA PHARMACEUTICALS ApS is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does XELLIA PHARMACEUTICALS ApS have on record?
1 shareholder is shown on record for XELLIA PHARMACEUTICALS ApS.
What is XELLIA PHARMACEUTICALS ApS's company registration number?
XELLIA PHARMACEUTICALS ApS's registration number is 61094628, filed with Danish Business Authority — CVR (Central Business Register) in Denmark. Its current status on the register is active.
Is XELLIA PHARMACEUTICALS ApS still an active company?
XELLIA PHARMACEUTICALS ApS's status on Danish Business Authority — CVR (Central Business Register) is listed as active.
When was XELLIA PHARMACEUTICALS ApS incorporated?
XELLIA PHARMACEUTICALS ApS was incorporated on 31 March 1959, according to Danish Business Authority — CVR (Central Business Register).
What is XELLIA PHARMACEUTICALS ApS's registered address?
The registered address on file for XELLIA PHARMACEUTICALS ApS is København S, Denmark.
What legal structure is XELLIA PHARMACEUTICALS ApS registered as?
XELLIA PHARMACEUTICALS ApS is registered as a Private limited company (Ltd.) in Denmark.
Who are the officers/directors of XELLIA PHARMACEUTICALS ApS?
Three of the 5 officer records shown for XELLIA PHARMACEUTICALS ApS are current appointments, filed with Danish Business Authority — CVR (Central Business Register). Stig Strobæk, Lars Fugger and Ole Jakob Muller all serve as Reel Ejer. The remaining 2 records shown (Frank Jensen and Jan Hogh Bergmann) are former appointments that have since been resigned. Management authority at XELLIA PHARMACEUTICALS ApS sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does XELLIA PHARMACEUTICALS ApS have a parent company or subsidiaries?
XELLIA PHARMACEUTICALS ApS sits 7 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark. 6 subsidiaries are recorded beneath it, across 7 jurisdictions. Those 6 subsidiaries span Denmark, Hong Kong, China, Hungary, Croatia, United States, and 1 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 6 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to XELLIA PHARMACEUTICALS ApS's ownership over time?
This profile reflects a point-in-time snapshot from Danish Business Authority — CVR (Central Business Register). Zavia's monitoring API can track changes to XELLIA PHARMACEUTICALS ApS's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access XELLIA PHARMACEUTICALS ApS's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Denmark, so records like XELLIA PHARMACEUTICALS ApS's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last synced on 28 September 2026.